Does oat bran lower cholesterol?
Yes, by a modest amount. A 2019 network meta-analysis of 55 randomized trials in 3,900 people ranked oat bran first among whole grains and brans, lowering LDL cholesterol by 12 mg/dL (95% CI 7.3 to 17; metric: 0.32 mmol/L, 0.19 to 0.44) against control. That ranking is indirect, and the trials used different amounts of bran. In people who already had high blood lipids, a 2024 meta-analysis of 17 trials in 1,731 people found oat products, oat bran among them, lowered LDL by 9.3 mg/dL (0.24 mmol/L), on moderate-certainty evidence.
Established. Oat bran lowers LDL cholesterol. Two meta-analyses of randomized trials agree on the direction and on a size of roughly a quarter to a third of a mmol/L. Both the EU and the US Food and Drug Administration accept the claim for oat beta-glucan, the soluble fiber that oat bran is rich in.
The first three rows are pooled analyses of randomized trials with their 95% confidence intervals. The last two come from one research group and are drawn without intervals because the cards do not carry them. Sources: cards ev-obc-01, ev-obc-02, oatb-c4-02 and oatb-c4-10 below.
What the trials found
How much you eat matters
In a 6-week randomized trial of 156 adults with high LDL, 2 oz (56 g) of oat bran a day lowered LDL by 15.9% against a farina control, and 84 g by 11.5%. The 28 g doses made no significant difference. These are percentage changes, and the abstract does not give them in mmol/L. A meta-analysis of 67 controlled trials put a number on the dose: each gram of soluble fiber from oat bran, psyllium or pectin lowered LDL by about 2.2 mg/dL (95% CI 1.7 to 2.7; metric: 0.057 mmol/L, 0.044 to 0.070), within intakes of 2 to 10 g a day. That is why the effect stays small at the amounts people actually eat. A 2014 meta-analysis of 28 trials found 3 g or more of oat beta-glucan a day lowered LDL by 9.7 mg/dL (95% CI 7.7 to 12; metric: 0.25 mmol/L, 0.20 to 0.30), and it included study reports from an oat ingredient company.
Who it works best in
A 1992 meta-analysis of 10 oat trials found total cholesterol fell by 5 mg/dL (0.13 mmol/L) overall, and more in people who started at 228 mg/dL (5.9 mmol/L) or above and ate 3 g or more of soluble fiber a day. Part of its data came from Quaker Oats. On a metabolic ward, 20 men with high cholesterol cut LDL by 12.1% in 21 days on oat bran, while wheat bran on an otherwise identical diet did nothing significant. The abstract does not give the dose. In 145 free-living adults with raised LDL on a cholesterol-lowering diet, 0.99 oz (28 g) of oat bran twice a day lowered LDL by 3.9%, while LDL rose 4.0% on wheat cereal and 6.4% on the diet alone. How much people responded depended on their age and sex.
The trials that found nothing
Two older trials found no advantage over wheat, and they are worth knowing about. In a 1990 double-blind crossover trial, 20 healthy adults with normal cholesterol ate 3.1 oz (87 g) of oat bran a day or low-fiber refined wheat for 6 weeks each. LDL ended at 2.69 against 107 mg/dL (2.77 mmol/L), not a significant difference. Both supplements lowered total cholesterol by 7 to 8%, and the authors traced all of that to people eating less saturated fat. The abstract does not say the order was randomized. In a 1991 crossover trial, 12 people with high blood lipids already on a lipid-lowering diet ate oat bran bread or wheat bran bread for 4 weeks each, and LDL did not change significantly on either. Twelve people is a small trial, and baking may matter.
Unsettled. Baking may blunt the effect, and the evidence for that is one research group. The same 5 to 6 g a day of oat bran beta-glucan lowered LDL by 10 mg/dL (0.26 mmol/L) (6.7%) when drunk in orange juice by 25 mildly hypercholesterolemic adults, and by 4.6 mg/dL (0.12 mmol/L), not a significant change, when baked into bread and cookies for 48 adults. Both samples were small.
Very large amounts do more, over a short time. In 24 young adults, adding 3.6 oz (102 g) of oat bran a day to a low-fiber diet for 2 weeks cut total cholesterol by 14% against 4% on the control diet. That is a dose far above typical intake, for two weeks only.
Who should be careful
Not for everyone. The side effects of oat bran are in the gut. Across the 17 trials in 1,731 people with high lipids, the adverse events reported were mostly diarrhea, nausea and flatulence. The abstract does not say how often they happened.
The phytate in oat bran is often said to block minerals. In 12 healthy adults eating 5 oz (142 g) of oat bran a day for 21 days, the share of zinc absorbed was 0.40 against 0.48 on a low-fiber diet (P = 0.07, not significant), and the total zinc absorbed was higher, 99 against 64 micromol. That was one small, very high dose study, and it measured zinc only.
People with celiac disease need oats that are certified free of gluten. Pooled trial and observational data in 661 patients found pure, uncontaminated oats in a gluten-free diet did not worsen symptoms or gut histology over 12 months, on low-quality evidence. Ordinary oats are a different matter. A meta-analysis of 40 food-testing studies found oats were the most contaminated of the gluten-free foods tested. We looked for an interaction between oat bran and statins and could not retrieve the source, so nothing about it is said here.
What expert bodies say
The US Food and Drug Administration allows a heart health claim for oat soluble fiber only in diets that supply 3 g or more of beta-glucan a day from whole oats or barley, and oat bran is one of the qualifying sources. The EU authorizes the claim that oat beta-glucan has been shown to lower blood cholesterol. The EU condition of use sits in a regulation we did not read for this page. We found no position from the American Heart Association or the National Lipid Association that names oat bran specifically.
How we searched
Searched: a local copy of the PubMed baseline for oat bran, oat beta-glucan, oat fiber or oats with cholesterol, LDL, lipids, non-HDL or apolipoprotein, across all study types (200 hits). A narrower search for oat bran with cholesterol, LDL or lipoprotein (62 hits, 4 reviews and about 45 trials). Searches for oat products and cholesterol (8 hits) and for fiber with statins (1 hit, fiber source not stated). The EU register of health claims and the US Code of Federal Regulations. ClinicalTrials.gov for oat bran (2 completed trials, no results posted, neither with LDL as the main outcome). A web search for meta-analyses from 2025 and 2026, which found nothing newer than 2024. Every included source was checked against Retraction Watch. Search run on 7 October 2026.
Included: four meta-analyses that name oat bran, four randomized trials, one older controlled trial with a null result, one zinc absorption study, and the FDA and EU texts. Three cards from our oat bran page and two from our review of oats and cholesterol, where they bear on dose, form and celiac disease.
Excluded: meta-analyses of oat beta-glucan or whole oats that are not specific to oat bran, which sit on the oats and cholesterol review. A trial of oat bran with niacin, where the drug dominates. A 2026 review of three fibers that gave no pooled estimate.
What we read: abstracts, from the PubMed baseline files, and the regulation and register texts.
What we could not get: a 1991 letter on oat bran and lovastatin absorption, which is not in our copy of PubMed. A position from a heart or lipid society that names oat bran.
What would change this answer
- A large placebo-controlled trial of oat bran lasting longer than 12 weeks that measures LDL and heart attacks and strokes. Every trial here measured cholesterol over weeks, and we found no registered trial of this kind.
- A trial comparing the same dose of oat bran in porridge, in bread and in a drink, to settle how much baking costs.
- Trials in people with normal cholesterol run with diet fat held constant, which would show whether the 1990 null result was the rule or the exception.
More on oat bran and oatmeal, side by side: oat bran and oatmeal →
The food behind this question
- Oat bran: the cholesterol effect is real and the size is known — numbers, evidence and safety
- Oat bran and oatmeal: both lower LDL, the bran ranks a little higher — numbers, evidence and safety
More questions about this food
- Do almonds lower cholesterol?
- Does apple cider vinegar lower cholesterol?
- Do avocados lower cholesterol?
- Is avocado oil good for cholesterol?
- Does beer raise cholesterol?
- Does beet juice lower cholesterol?
- Is canola oil good or bad for cholesterol?
- Is cheese bad for cholesterol?
- Does coconut oil raise cholesterol?
- Does coffee raise cholesterol?
The same question for other foods (cholesterol)
Sources
- ev-obc-01 · Meta-analysis or systematic review · network meta-analysis of randomized trials · n = 55 trials, 3900 participants
Cumulative ranking analyses showed that oat bran was the most effective intervention strategy for TC and LDL-C improvements, with significant decreases of - 0.35 mmol/L (95% CI - 0.47, - 0.23 mmol/L) and - 0.32 mmol/L (95% CI - 0.44, - 0.19 mmol/L) in TC and LDL-C compared with control, respectively.
Who: randomized trials of whole grains and brans (oat bran, oat, barley, brown rice, wheat, wheat bran) on blood lipidsEffect: oat bran vs control: TC -0.35 mmol/L (95% CI -0.47 to -0.23), LDL-C -12 mg/dL (-17 to -7.3; metric: -0.32 mmol/L, -0.44 to -0.19); oat second; barley, brown rice, wheat, wheat bran ineffectiveCertainty: The ranking of the network meta-analysis is indirect; bran doses differ across studies.Eur J Nutr, 2019 · checked 2026-10-07 · we read the abstract - ev-obc-02 · Meta-analysis or systematic review · systematic review and meta-analysis of RCTs · n = 17 trials, 1731 subjects
Pooled estimates showed that oat-based products may result in a large reduction in LDL-C (WMD, -0.24 mmol L-1; 95% CI: -0.33, -0.15) (moderate certainty) and TC (WMD, -0.32 mmol L-1; 95% CI: -0.48, -0.17) (moderate certainty).
Who: patients with dyslipidemia in RCTs of oat-based products (oat beta-glucan, oat bran, wholegrain oat) for at least 4 weeksEffect: LDL-C WMD -9.3 mg/dL (95% CI -13 to -5.8; metric: -0.24 mmol/L, -0.33 to -0.15), TC -12 mg/dL (-19 to -6.6; metric: -0.32 mmol/L, -0.48 to -0.17), moderate certainty (GRADE); little effect on HDL-C and TGCertainty: Bran together with other oat products; risk of bias high or with concerns.Food Funct, 2024 · checked 2026-10-07 · we read the abstract - ev-obc-03 · Meta-analysis or systematic review · meta-analysis of controlled trials · n = 67 trials
Soluble fiber, 2-10 g/d, was associated with small but significant decreases in total cholesterol [-0.045 mmol L(-1).g soluble fiber(-1) (95% CI: -0.054, -0.035)] and LDL cholesterol [-0.057 mmol.L(-1).g(-1) (95% CI: -0.070, -0.044)].
Who: controlled trials of pectin, oat bran, guar gum and psyllium, soluble fiber 2-10 g/dayEffect: LDL-C -2.2 mg/dL (-0.057 mmol/L) per g soluble fiber (95% CI -0.070 to -0.044); total cholesterol -1.7 mg/dL (-0.045 mmol/L) per g; oat, psyllium and pectin not differentCertainty: Regression per gram; mixed designs of controlled studies.Am J Clin Nutr, 1999 · checked 2026-10-07 · we read the abstract - ev-obc-04 · Meta-analysis or systematic review · meta-analysis of randomized controlled trials · n = 20 trials identified, 10 pooled
Larger reductions were seen in trials in which subjects had initially higher blood cholesterol levels (greater than or equal to 5.9 mmol/L [greater than or equal to 229 mg/dL]), particularly when a dose of 3 g or more of soluble fiber was employed.
Who: randomized controlled trials of oat products (oat bran and oatmeal) with diet and body weight assessment, to March 1991Effect: total cholesterol -0.13 mmol/L (-5.9 mg/dL), 95% CI -7.3 to -0.66 mg/dL (-0.19 to -0.017 mmol/L); larger with baseline >= 228 mg/dL (5.9 mmol/L) and >= 3 g soluble fiberCertainty: Part of the data was provided by Quaker Oats; LDL separately not given in the abstract.JAMA, 1992 · checked 2026-10-07 · we read the abstract - ev-obc-05 · Randomized controlled trial(s) · randomized controlled dose-response trial · n = 156
Fifty-six grams of oat bran resulted in significantly greater reductions in LDL-C levels than 56 g of oatmeal.
Who: adults with LDL-C above 160 mg/dL (4.14 mmol/L), or 130-160 mg/dL (3.37-4.14 mmol/L) with multiple risk factors; oatmeal or oat bran at 28, 56 or 84 g dry weight daily vs 28 g farinaEffect: LDL-C -10.1% (84 g oatmeal), -15.9% (56 g oat bran), -11.5% (84 g oat bran) vs farina at week 6; 28 g doses not significantCertainty: Percent reduction in the groups; 0.99 oz (28 g) of bran gave no significant effect.JAMA, 1991 · checked 2026-10-07 · we read the abstract - ev-obc-06 · Randomized controlled trial(s) · randomized controlled metabolic ward trial · n = 20
After 21 d, OB significantly decreased total cholesterol by 12.8% (P less than 0.001), low-density-lipoprotein cholesterol by 12.1% (P less than 0.004), and apolipoprotein B-100 by 13.7% (P less than 0.001) whereas WB had no significant effect.
Who: hypercholesterolemic men on a metabolic ward, oat bran or wheat bran diets identical except for soluble fiberEffect: oat bran: total cholesterol -12.8% (P < 0.001), LDL-C -12.1% (P < 0.004), apoB-100 -13.7%; wheat bran no significant effectCertainty: The bran dose is not given in the abstract; men only, 21 days.Am J Clin Nutr, 1991 · checked 2026-10-07 · we read the abstract - ev-obc-07 · Randomized controlled trial(s) · randomized controlled blinded crossover trial · n = 145 completers (82% of randomized)
Blood lipid studies demonstrated significantly greater reductions in total cholesterol (average -2.2%) and LDL cholesterol (average -3.9%) in the oat-bran groups than in the wheat-cereal groups (average total cholesterol +3.3%, average LDL cholesterol +4.0%) or in the diet alone group (total cholesterol +6.0%; LDL cholesterol +6.4%).
Who: men and women aged 20 to 70 with baseline LDL in the 50th to 95th percentile, AHA step I diet plus oat bran 28 g twice daily vs wheat cerealEffect: LDL-C -3.9% (oat bran) vs +4.0% (wheat cereal) vs +6.4% (diet alone); total cholesterol -2.2% vs +3.3% vs +6.0%Certainty: The response depended on age and sex (P < .001); no absolute values in the abstract.J Fam Pract, 1991 · checked 2026-10-07 · we read the abstract - ev-obc-08 · Observational data · double-blind crossover controlled trial · n = 20
Those changes in dietary fats were sufficient to explain all of the reduction in serum cholesterol levels caused by the high-fiber and low-fiber diets.
Who: healthy subjects aged 23 to 49, isocaloric supplements of high-fiber oat bran (87 g/day) or low-fiber refined wheat, six weeks eachEffect: LDL 104 vs 107 mg/dL (2.69 vs 2.77 mmol/L) (oat bran vs low-fiber wheat), not significant; both lowered baseline total cholesterol by 7-8%, explained by less saturated fat in the dietCertainty: Normal baseline cholesterol (186 mg/dL (4.8 mmol/L)); randomization not named in the abstract. A key negative result from 1990.N Engl J Med, 1990 · checked 2026-10-07 · we read the abstract - ev-obc-09 · Randomized controlled trial(s) · randomized single-blind crossover trial · n = 12
We conclude that this oat bran bread consumed as part of a lipid-correcting diet did not influence lipoproteins to any greater extent than wheat bread of similar total fibre content.
Who: hyperlipidemic subjects aged 38 to 66 stabilized on lipid-lowering diets for at least three months; oat bran bread vs wheat bran bread, four weeks eachEffect: cholesterol, triglyceride and LDL-C did not change significantly in either period; both diets lowered serum cholesterol about 4%Certainty: Small sample; beta-glucan in bread may lose viscosity after baking.Aust N Z J Med, 1991 · checked 2026-10-07 · we read the abstract - ev-obc-10 · Meta-analysis or systematic review · systematic review and meta-analysis of RCTs · n = 17 trials, 1731 subjects
Oat-related adverse events were mostly gastrointestinal such as diarrhea, nausea, and flatulence being the most prevalent.
Who: patients with dyslipidemia in RCTs of oat-based products including oat branEffect: adverse events mostly gastrointestinal (diarrhea, nausea, flatulence); no difference in major cardiovascular events in one trialCertainty: No adverse event frequencies in the abstract.Food Funct, 2024 · checked 2026-10-07 · we read the abstract - ev-obc-11 · Observational data · controlled crossover feeding study · n = 12
In conclusion, the absorption of zinc was high and not affected by addition of oat bran.
Who: healthy subjects (6 men, 6 women), oat bran in bread at three main meals vs identical low-fiber diet, stable zinc isotopesEffect: fractional zinc absorption 0.48 (low fiber) vs 0.40 (oat bran), P = 0.07; absorbed zinc 64 vs 99 micromol, P = 0.009Certainty: Randomization not named; very high dose; zinc only.J Nutr, 2000 · checked 2026-10-07 · we read the abstract - ev-obc-12 · Position of an expert body · federal regulation text · n = —
( 1 ) 3 g or more per day of β-glucan soluble fiber from either whole oats or barley, or a combination of whole oats and barley.
Who: 21 CFR 101.81(c), soluble fiber from certain foods and coronary heart diseaseEffect: qualifying intake: 3 g/day or more of beta-glucan soluble fiber from whole oats or barleyCertainty: Regulator decision, not an effect assessment.21 CFR 101.81, Health claims: Soluble fiber from certain foods and risk of coronary heart disease (CHD) · checked 2026-10-07 · we read the section - ev-obc-13 · Position of an expert body · regulatory register entry · n = —
POL-HC-6248 Oat beta-glucan Oat beta-glucan has been shown to lower/reduce blood cholesterol. High cholesterol is a risk factor in the development of coronary heart disease -/- Authorised
Who: EU Register of nutrition and health claims, claim POL-HC-6248Effect: authorizedCertainty: The condition of use (3 g beta-glucan per day) is in Regulation 1160/2011, not in the register snapshot.EU Register on nutrition and health claims, claim POL-HC-6248, snapshot 2026-09-21 · checked 2026-10-07 · we read the dataset - oatb-c4-02 · Meta-analysis or systematic review · meta-analysis of randomized controlled trials with meta-regression · n = 28 RCTs
OBG in doses of ≥3 g/d reduced low-density lipoprotein (LDL) and total cholesterol relative to control by 0.25 mmol/L (95% CI: 0.20, 0.30; P < 0.0001) and 0.30 mmol/L (95% CI: 0.24, 0.35; P < 0.0001), respectively...There was a significantly greater effect for both LDL and total cholesterol in subjects with diabetes compared with those without (although based on few studies).
Who: adults in 28 RCTs comparing at least 3 g/d oat beta-glucan with control, 2-12 weeks, doses 3.0-12.4 g/dEffect: LDL -9.7 mg/dL (95% CI 7.7 to 12; metric: -0.25 mmol/L, 0.20 to 0.30), TC -0.30 (0.24-0.35); HDL and TG unchanged; no dose or duration effectCertainty: Includes in-house study reports from an oat ingredient company (CreaNutrition AG).Am J Clin Nutr, 2014 · checked 2026-09-23 · we read the abstract - oatb-c4-06 · Randomized controlled trial(s) · double-blind randomized crossover trial · n = 24
A double-blind, randomized crossover study in 24 adults (age 25.2±2.7 years; body mass index: 24.9±2.9 kg/m2), who completed two 2-week dietary intervention periods: low-fiber diet (control) or an oat bran (control +102 g oat bran/day) diet...Total cholesterol decreased by 14% during the oat bran period compared with 4% during the control period (P<0.001)...energy excretion was increased by 37% (1014 vs 638 kJ/day, P<0.001)
Who: 24 healthy adults aged about 25, double-blind randomized crossover, two 2-week periodsEffect: TC -14% vs -4%; non-HDL-C -16% vs -3%; TG -21% vs -10%; energy excretion 1014 vs 638 kJ/day; body weight unchangedCertainty: Two weeks only; dose far above typical intake.Eur J Clin Nutr, 2011 · checked 2026-09-23 · we read the abstract - oatb-c4-10 · Randomized controlled trial(s) · two randomized controlled studies, parallel then crossover · n = 48 and 25
In study 1, the change in LDL cholesterol did not differ significantly (-0.12 mmol/L; P = 0.173) between the 2 groups. In study 2, the drink rich in beta-glucan decreased LDL cholesterol by 0.26 +/- 0.07 mmol/L (6.7 +/- 1.8%; P = 0.001) and the ratio of total to HDL cholesterol by 0.26 +/- 0.11 (5.4 +/- 2.1%; P = 0.029) compared with the other drink...The food matrix or the food processing, or both, could have adverse effects on the hypocholesterolemic properties of oat beta-glucan.
Who: 48 mildly hypercholesterolemic adults (bread and cookies, 4 weeks) and 25 of them (juice, 2-week crossover)Effect: bread and cookies: LDL change -4.6 mg/dL (-0.12 mmol/L) (P = 0.173); juice: LDL -10 mg/dL (-0.26 mmol/L) (6.7%, P = 0.001), TC/HDL ratio -0.26Certainty: Suggests processing or matrix blunts the effect; small samples.Am J Clin Nutr, 2003 · checked 2026-09-23 · we read the abstract - ev-oatchol-08 · Observational data · systematic review and meta-analysis of trials and observational studies · n = 661
Oat consumption for 12 months did not affect symptoms (standardized mean difference: reduction in symptom scores in patients who did and did not consume oats, -0.22; 95% CI, -0.56 to 0.13; P = .22)
Who: patients with celiac disease on a gluten-free diet, pure/uncontaminated oats, adults and childrenEffect: symptom score SMD -0.22 (95% CI -0.56 to 0.13); histology RR 0.24 (0.01-4.8); no change in serologyCertainty: Low quality of evidence and few studies per endpoint; applies only to pure oats, not ordinary oats that may carry wheat or barley.Gastroenterology, 2017 · checked 2026-10-06 · we read the abstract - ev-oatchol-09 · Laboratory or animal data · meta-analysis of food contamination analyses · n = —
Moreover, it was noticed that oats were the most contaminated food.
Who: laboratory analyses of gluten-free foods, labeled and naturally gluten-free, 40 studiesEffect: overall contamination above 20 mg/kg 15.12% (95% CI 9.56-21.70%); naturally gluten-free foods 28.32%; oats most contaminatedCertainty: Food testing, not human outcomes; oat-specific rate not given in the abstract.Br J Nutr, 2022 · checked 2026-10-06 · we read the abstract
How this page was made. Evidence was extracted from primary sources into cards, every number was re-checked against the source, and the text was written from those cards. Bioma Learn has no human medical reviewer at this time, and we say so rather than invent one. Methodology. This is information, not medical advice.